The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is a common malignancy, and the hepatitis B virus (HBV) is its major pathogenic factor. Over the past decades, it has been confirmed that HBV infection could promote disease progression through a variety of mechanisms, ultimately leading to the malignant transformation of liver cells. Many factors have been identified in the pathogenesis of HBV-associated HCC (HBV-HCC), including HBV gene integration, genomic instability caused by mutation, and activation of cancer-promoting signaling pathways. As research in the progression of HBV-HCC progresses, the role of many new mechanisms, such as epigenetics, exosomes, autophagy, metabolic regulation, and immune suppression, is also being continuously explored. The occurrence of HBV-HCC is a complex process caused by interactions across multiple genes and multiple steps, where the synergistic effects of various cancer-promoting mechanisms accelerate the process of disease evolution from inflammation to tumorigenesis. In this review, we aim to provide a brief overview of the mechanisms involved in the occurrence and development of HBV-HCC, which may contribute to a better understanding of the role of HBV in the occurrence and development of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Epigenetic plasticity and the hallmarks of cancer
Flavahan, W. A., Gaskell, E., & Bernstein, B. E. (2017) · Science · doi:10.1126/science.aal2380 · Cited by 1,340 · cited 2×
“66 HBV can cause epigenetic remodeling by changing the methylation state of DNA and the post-translational modification of histones, which is an important pathogenesis mechanism of HBV-associated HCC. Bioinformatics analysis showed that the methylation levels of tumor tissues from patients with…”
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., Huang, C., Li, J., Dong, X., Zhou, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.052 · Cited by 1,096
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Venook, A. P., Papandreou, C., Furuse, J., & Ladrón de Guevara, L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-05 · Cited by 965
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K. A., Hosoda, F., Nguyen, H. H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2291 · Cited by 870
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Totoki, Y., Tatsuno, K., Covington, K. R., Ueda, H., Creighton, C. J., Kato, M., Tsuji, S., Donehower, L. A., Slagle, B. L., Nakamura, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3126 · Cited by 781 · cited 2×
“In addition, it has also been confirmed that many genes, including TERT, ARID1A, ARID2, and NFE2L2, are mutated in HBV-associated HCC.(13,14) These genes have been shown to be closely related to the occurrence of a variety of malignant tumors, including HCC,”
Donato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity
Li, J., Liu, K., Liu, Y., Xu, Y., Zhang, F., Yang, H., Liu, J., Pan, T., Chen, J., Wu, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2647 · Cited by 509
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Monga, S. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.056 · Cited by 487
Yuan, X., Larsson, C., & Xu, D. (2019) · Oncogene · doi:10.1038/s41388-019-0872-9 · Cited by 450
Rautou, P.-E., Mansouri, A., Lebrec, D., Durand, F., Valla, D., & Moreau, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.006 · Cited by 383
Lim, C. J., Lee, Y. H., Pan, L., Lai, L., Chua, C., Wasser, M., Lim, T. K. H., Yeong, J., Toh, H. C., Lee, S. Y., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316510 · Cited by 357
Yu, X., Lan, P., Hou, X., Han, Q., Lu, N., Li, T., Jiao, C., Zhang, J., Zhang, C., & Tian, Z. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.018 · Cited by 356
Self-citationGenomic and oncogenic preference of HBV integration in hepatocellular carcinoma
Zhao, L.-H., Liu, X., Yan, H.-X., Li, W.-Y., Zeng, X., Yang, Y., Zhao, J., Liu, S.-P., Zhuang, X.-H., Lin, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms12992 · Cited by 344
Self-citationFisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., Salerno, D., Boni, C., Massari, M., Cavallo, M. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4275 · Cited by 341
Sir, D., Tian, Y., Chen, W.-L., Ann, D. K., Yen, T.-S. B., & Ou, J.-H. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911373107 · Cited by 336
Aberrant Epigenetic Modifications in Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein
Park, I. Y., Sohn, B. H., Yu, E., Suh, D. J., Chung, Y., Lee, J., Surzycki, S. J., & Lee, Y. I. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.034 · Cited by 320
Subversion of Cellular Autophagy Machinery by Hepatitis B Virus for Viral Envelopment
Li, J., Liu, Y., Wang, Z., Liu, K., Wang, Y., Liu, J., Ding, H., & Yuan, Z. (2011) · Journal of Virology · doi:10.1128/jvi.02627-10 · Cited by 293
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications
Pollicino, T., Cacciola, I., Saffioti, F., & Raimondo, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.041 · Cited by 277
Bréchot, C., Gozuacik, D., Murakami, Y., & Paterlini-Bréchot, P. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0321 · Cited by 276
Liu, Y., Tao, S., Liao, L., Li, Y., Li, H., Li, Z., Lin, L., Wan, X., Yang, X., & Chen, L. (2020) · Nature Communications · doi:10.1038/s41467-019-14190-2 · Cited by 265
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
D'souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5759 · Cited by 257
The role of telomeres and telomerase in cirrhosis and liver cancer
Nault, J.-C., Ningarhari, M., Rebouissou, S., & Zucman-Rossi, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0165-3 · Cited by 239
Wang, W., Zhou, X., Bian, Y., Wang, S., Chai, Q., Guo, Z., Wang, Z., Zhu, P., Peng, H., Yan, X., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0648-y · Cited by 239
Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction
Yang, Y., Han, Q., Hou, Z., Zhang, C., Tian, Z., & Zhang, J. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.24 · Cited by 225
Self-citationMak, L.-Y., Wong, D. K.-H., Pollicino, T., Raimondo, G., Hollinger, F. B., & Yuen, M.-F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.042 · Cited by 223
Raziorrouh, B., Schraut, W., Gerlach, T., Nowack, D., Gru¨ ner, N. H., Ulsenheimer, A., Zachoval, R., Wa¨chtler, M., Spannagl, M., Haas, J. R., et al. (2010) · Hepatology · doi:10.1002/hep.23936 · Cited by 214
Liu, Q., Li, F., Zhuang, Y., Xu, J., Wang, J., Mao, X., Zhang, Y., & Liu, X. (2019) · Gut Pathogens · doi:10.1186/s13099-018-0281-6 · Cited by 208
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Sun, C., Sun, H., Zhang, C., & Tian, Z. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.91 · Cited by 200
Lin, X., Li, A.-M., Li, Y.-H., Luo, R.-C., Zou, Y.-J., Liu, Y.-Y., Liu, C., Xie, Y.-Y., Zuo, S., Liu, Z., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0111-4 · Cited by 191
Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis
Ivanov, A. V., Valuev-Elliston, V. T., Tyurina, D. A., Ivanova, O. N., Kochetkov, S. N., Bartosch, B., & Isaguliants, M. G. (2017) · Oncotarget · doi:10.18632/oncotarget.13904 · Cited by 186
A model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention
Wild, C. P., & Montesano, R. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.053 · Cited by 185
Tjwa, E. T. T. L., van Oord, G. W., Hegmans, J. P., Janssen, H. L. A., & Woltman, A. M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.009 · Cited by 181
Lan, S.-H., Wu, S.-Y., Zuchini, R., Lin, X.-Z., Su, I.-J., Tsai, T.-F., Lin, Y.-J., Wu, C.-T., & Liu, H.-S. (2014) · Hepatology · doi:10.1002/hep.26659 · Cited by 180
Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
Zhou, L., He, R., Fang, P., Li, M., Yu, H., Wang, Q., Yu, Y., Wang, F., Zhang, Y., Chen, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20316-8 · Cited by 178
Liu, C.-J., & Kao, J.-H. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345716 · Cited by 177
Kapil, S., Duseja, A., Sharma, B. K., Singla, B., Chakraborti, A., Das, A., Ray, P., Dhiman, R. K., & Chawla, Y. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13058 · Cited by 173
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Xie, Y. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5765-6_2 · Cited by 173
Human Hepatitis B Virus-X Protein Alters Mitochondrial Function and Physiology in Human Liver Cells
Lee, Y. I., Hwang, J. M., Im, J. H., Lee, Y. I., Kim, N. S., Kim, D. G., Yu, D. Y., Moon, H. B., & Park, S. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309280200 · Cited by 171
Bolukbas, C., Bolukbas, F. F., Horoz, M., Aslan, M., Celik, H., & Erel, O. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-95 · Cited by 169
Kim, G., Imam, H., Khan, M. A., Mir, S. A., Kim, S., Yoon, S. K., Hur, W., & Siddiqui, A. (2020) · Hepatology · doi:10.1002/hep.31313 · Cited by 166
Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.
Matsubara, K., & Tokino, T. (1990) · PubMed · Cited by 161
Yoo, Y.-G., Na, T.-Y., Seo, H.-W., Seong, J. K., Park, C. K., Shin, Y. K., & Lee, M.-O. (2008) · Oncogene · doi:10.1038/sj.onc.1211000 · Cited by 159
Chen, W., Jiang, J., Gong, L., Shu, Z., Xiang, D., Zhang, X., Bi, K., & Diao, H. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01803-8 · Cited by 150
Zeng, Y., Chen, S., Fu, Y., Wu, W., Chen, T., Chen, J., Yang, B., & Ou, Q. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13216 · Cited by 148
Salerno, D., Chiodo, L., Alfano, V., Floriot, O., Cottone, G., Paturel, A., Pallocca, M., Plissonnier, M., Jeddari, S., Belloni, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319637 · Cited by 145
Sze, K. M., Chu, G. K. Y., Lee, J. M. F., & Ng, I. O. (2012) · Hepatology · doi:10.1002/hep.25979 · Cited by 144
Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C
Fujita, N., Sugimoto, R., Ma, N., Tanaka, H., Iwasa, M., Kobayashi, Y., Kawanishi, S., Watanabe, S., Kaito, M., & Takei, Y. (2008) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.00972.x · Cited by 141
Hsieh, A., Kim, H.-S., Lim, S., Yu, D., & Jung, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.018 · Cited by 136
Huang, M., Chen, C. Y., Geng, J., Han, D. H., Wang, T., Xie, T., Wang, L., Wang, Y., Wang, C., Lei, Z., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.038 · Cited by 136
Chung, T., Lee, Y., Ko, J., & Kim, C. (2003) · PubMed · Cited by 135
Zhang, H., Zhang, Y., Zhu, X., Chen, C., Zhang, C., Xia, Y., Zhao, Y., ANDRISANI, O. M., & Kong, L. (2018) · Hepatology · doi:10.1002/hep.30300 · Cited by 132
Yao, Z., Qiao, Y., Li, X., Chen, J., Ding, J., Bai, L., Shen, F., Shi, B., Liu, J., Peng, L., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01578-18 · Cited by 132
Liang, H., Wang, N., Wang, Y., Wang, F., Fu, Z., Yan, X., Zhu, H., Diao, W., Ding, Y., Chen, X., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.013 · Cited by 124
Liu, X., Li, M., Wang, X., Dang, Z., Jiang, Y., Wang, X., Kong, Y., & Yang, Z. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02426-5 · Cited by 116
Self-citationmiR-146a negatively regulates NK cell functions via STAT1 signaling
Xu, D., Han, Q., Hou, Z., Zhang, C., & Zhang, J. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.113 · Cited by 114
Self-citationLou, W., Liu, J., Ding, B., Chen, D., Xu, L., Ding, J., Jiang, D., Zhou, L., Zheng, S., & Fan, W. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-018-1761-7 · Cited by 112
Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection
Faure‐Dupuy, S., Delphin, M., Aillot, L., Dimier, L., Lebossé, F., Fresquet, J., Parent, R., Matter, M. S., Rivoire, M. L., Bendriss‐Vermare, N., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.032 · Cited by 112
Zhao, J., Wu, G., Bu, F., Lü, B., Liang, A., Cao, L., Tong, X., Lü, X., Wu, M., & Guo, Y. (2009) · Hepatology · doi:10.1002/hep.23247 · Cited by 109
Saitta, C., Tripodi, G., Barbera, A., Bertuccio, A., Smedile, A., Ciancio, A., Raffa, G., Sangiovanni, A., Navarra, G., Raimondo, G., et al. (2015) · Liver International · doi:10.1111/liv.12807 · Cited by 109
Valgimigli, M., Valgimigli, L., Treré, D., Gaiani, S., Pedulli, G. F., Gramantieri, L., & Bolondi, L. (2002) · Free Radical Research · doi:10.1080/107156021000006653 · Cited by 108
Choi, Y.-M., Lee, S.-Y., & Kim, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030597 · Cited by 108
Yuan, K., Lei, Y., Chen, H.-N., Chen, Y., Zhang, T., Li, K., Xie, N., Wang, K., Feng, X., Pu, Q., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.129 · Cited by 105
Wang, J., Chen, J., Liu, Y., Zeng, X., Wei, M., Wu, S., Xiong, Q., Song, F., Xu, Y., Xiao, Y., et al. (2018) · Hepatology · doi:10.1002/hep.30248 · Cited by 103
An HBV-encoded miRNA activates innate immunity to restrict HBV replication
Zhao, X., Sun, L., Mu, T., Yi, J., Ma, C., Xie, H. Y., Liu, M., & Tang, H. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz104 · Cited by 99
Sartorius, K., Makarova, J. A., Sartorius, B. K. D., An, P., Winkler, C. A., Chuturgoon, A. A., & Kramvis, A. (2019) · Cells · doi:10.3390/cells8121504 · Cited by 95
Zhang, Y., Yan, Q., Gong, L., Xu, H., Liu, B., Fang, X., Yu, D., Li, L., Wei, T., Wang, Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01593-5 · Cited by 95
Liu, Y., Ye, X., Zhang, J.-B., Ouyang, H., Shen, Z., Wu, Y., Wang, W., Wu, J., Tao, S., Yang, X., et al. (2015) · Oncogene · doi:10.1038/onc.2015.7 · Cited by 93
Self-citationAiming for cure in HBV and HDV infection
Petersen, J., Thompson, A. J. V., & Levrero, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.043 · Cited by 91
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
Wang, G., Dong, F., Xu, Z., Sharma, S. P., Hu, X., Chen, D., Zhang, L., Zhang, J., & Dong, Q. (2017) · BMC Cancer · doi:10.1186/s12885-017-3816-1 · Cited by 91
Self-citationModulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α
Dai, X., Zhang, W., Zhang, H., Sun, S., Yu, H., Guo, Y., Kou, Z., Zhao, G., Du, L., Jiang, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku260 · Cited by 88
Self-citationBreakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
Zong, L., Peng, H. C., Sun, C., Li, F., Zheng, M., Chen, Y., Wei, H., Sun, R., & Tian, Z. (2019) · Nature Communications · doi:10.1038/s41467-018-08096-8 · Cited by 86
Sze, K. M., Ho, D. W., Chiu, Y., Tsui, Y., Chan, L., Lee, J. M., Chok, K., Chan, A. C. Y., Tang, C. N., Tang, V. W., et al. (2020) · Hepatology · doi:10.1002/hep.31231 · Cited by 86
Liu, Y., Ye, S., Zhao, X., Ji, L., Zhang, Y., Zhou, P., Sun, J., Guan, Y., Han, Y., Ni, C., et al. (2018) · Journal of Cancer · doi:10.7150/jca.26052 · Cited by 83
Wong, D. K.-H., Cheng, S. C. Y., Mak, L., To, E. W.-P., Lo, R. C., Cheung, T. T., Seto, W., Fung, J., Man, K., Lai, C., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.06.029 · Cited by 83
A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma
Chen, S.-L., Zhang, C. Z., Liu, L.-L., Lu, S.-X., Pan, Y.-H., Wang, C., He, Y.-F., Lin, C.-S., Yang, X., Xie, D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2357 · Cited by 82
Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma
Hu, C., Li, W., Tian, F., Jiang, K., Liu, X., Cen, J., He, Q., Qiu, Z., Kienast, Y., Wang, Z., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.028 · Cited by 80
Chen, Y.-Y., Wang, W., Che, L., Lan, Y., Zhang, L., Zhan, D.-L., Huang, Z., Lin, Z., & Lin, Y. (2020) · Cancers · doi:10.3390/cancers12030655 · Cited by 79
Wang, M.-D., Wu, H., Huang, S., Zhang, H., Qin, C., Zhao, L., Fu, G., Zhou, X., Wang, X., Tang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6817 · Cited by 76
Mao, K., Zhang, J., He, C., Xu, K., Liu, J., Sun, J. M., Wu, G., Tan, C., Zeng, Y., Wang, J., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.004 · Cited by 70
Self-citationKapoor, N. R., Chadha, R., Kumar, S., Choedon, T., Reddy, V. S., & Kumar, V. (2017) · Virus Research · doi:10.1016/j.virusres.2017.08.009 · Cited by 70
The role of HBV-induced autophagy in HBV replication and HBV related-HCC
Xie, M., Yang, Z., Liu, Y., & Zheng, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.051 · Cited by 70
Exosomes as adjuvants for the recombinant hepatitis B antigen: First report
Jesus, S., Soares, E. F. P., Cruz, M. T., & Borges, O. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.09.029 · Cited by 69
Ha, H. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i39.4932 · Cited by 68
microRNAs: Key players in virus‐associated hepatocellular carcinoma
Nahand, J. S., Bokharaei‐Salim, F., Salmaninejad, A., Nesaei, A., Mohajeri, F., Moshtzan, A., Tabibzadeh, A., Karimzadeh, M. R., Moghoofei, M., Marjani, A., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27956 · Cited by 67
The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes
Kakizaki, M., Yamamoto, Y., Yabuta, S., Kurosaki, N., Kagawa, T., & Kotani, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205886 · Cited by 65
Lin, Y., Wu, C., Wang, X., Kemper, T., Squire, A., Gunzer, M., Zhang, J., Chen, X., & Lu, M. (2018) · Protein & Cell · doi:10.1007/s13238-018-0555-2 · Cited by 62
Self-citationGao, W., Jia, Z., Tian, Y., Yang, P., Sun, H., Wang, C., Ding, Y., Zhang, M., Zhang, Y., Yang, D., et al. (2019) · Hepatology · doi:10.1002/hep.30947 · Cited by 60
Modulation of Wnt signaling pathway by hepatitis B virus
Daud, M., Rana, M. A., Husnaın, T., & Ijaz, B. (2017) · Archives of Virology · doi:10.1007/s00705-017-3462-6 · Cited by 54
Liu, D., Li, P., Guo, J., Li, L., Guo, B., Jiao, H., Wu, J., & Chen, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9584 · Cited by 53
miR146a impairs the IFN ‐induced anti‐ HBV immune response by downregulating STAT 1 in hepatocytes
Hou, Z., Han, Q., Zhang, C., Tian, Z. G., & Zhang, J. (2013) · Liver International · doi:10.1111/liv.12244 · Cited by 52
Self-citationShi, Y., Du, L., Lv, D., Li, H., Shang, J., Lu, J., Zhou, L., Bai, L., & Tang, H. (2019) · Hepatology · doi:10.1002/hep.30548 · Cited by 49
Hepatitis B virus x protein induces autophagy via activating death‐associated protein kinase
Zhang, H., Chen, G. G., Hu, B., Zhang, Z., Yun, J., He, M., & Lai, P. B. S. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12191 · Cited by 48
Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a
Hou, Z., Zhang, J., Han, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep26150 · Cited by 48
Self-citationWu, S., Lan, S., & Liu, H. (2019) · Autophagy · doi:10.1080/15548627.2019.1569918 · Cited by 47
O ‐GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels
Wang, X., Lin, Y., Liu, S., Zhu, Y., Lu, K., Broering, R., & Lu, M. (2020) · The FASEB Journal · doi:10.1096/fj.202001168rr · Cited by 47
Montalbano, R., Honrath, B., Wissniowski, T. T., Elxnat, M., Roth, S., Ocker, M., Quint, K., Churin, Y., Roderfeld, M., Schroeder, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7950 · Cited by 45
Fisicaro, P., Boni, C., Barili, V., Laccabue, D., & Ferrari, C. I. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.01.003 · Cited by 44
Lee, W. Y., Bachtiar, M., Choo, C. C. S., & Lee, C. G. L. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12457 · Cited by 44
Ning, Y., Feng, W., Cao, X., Ren, K., Quan, M., Chen, A., Xu, C., Qiu, Y., Cao, J., Li, X., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01958-y · Cited by 44
Li, K., Liu, H., & Guo, T. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.12.004 · Cited by 42
Tajiri, K., Baba, H., Kawai, K., Minemura, M., Yasumura, S., Takahara, T., & Sugiyama, T. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13287 · Cited by 41
Synaptosomal‐associated protein 29 is required for the autophagic degradation of hepatitis B virus
Lin, Y., Wu, C., Wang, X., Liu, S., Kemper, T., Li, F., Squire, A., Zhu, Y., Zhang, J., Chen, X., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801995rr · Cited by 40
Self-citationChiu, A. P., Tschida, B. R., Sham, T.-T., Lo, L. H., Moriarity, B. S., Li, X., Lo, R. C., Hinton, D. E., Rowlands, D. K., Chan, C.-O., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1127 · Cited by 38
Xie, H., Xie, D., Zhang, J., Jin, W., Li, Y., Yao, J., Pan, Z., & Xie, D. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.08.014 · Cited by 38
Self-citationAkt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation
Khattar, E., Mukherji, A., & Kumar, V. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08514.x · Cited by 37
Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma
Morishita, A., Fujita, K., Iwama, H., Chiyo, T., Fujihara, S., Oura, K., Tadokoro, T., Mimura, S., Nomura, T., Tani, J., et al. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00269.2019 · Cited by 36
The association between hepatitis B mutants and hepatocellular carcinoma
Fangfang, W., Zheng, Q., Li, M., & Wu, M. (2017) · Medicine · doi:10.1097/md.0000000000006835 · Cited by 35
Kong, X., Lv, Y., Shao, L., Nong, X.-Y., Zhang, G., Zhang, Y., Fan, H., Liu, M., Li, X., & Tang, H. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0949-y · Cited by 34
miR-146 promotes HBV replication and expression by targeting ZEB2
Wang, Y., & Li, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.097 · Cited by 33
Zhao, H., Han, Q., Wang, G., Lin, A., Xu, D., Wang, Y., Zhao, L., Tian, Z., & Zhang, J. (2019) · Gut · doi:10.1136/gutjnl-2017-315588 · Cited by 33
Self-citationSTAT3 directly regulates NKp46 transcription in NK cells of HBeAg-negative CHB patients
Zheng, B., Yang, Y., Han, Q., Yin, C., Pan, Z., & Zhang, J. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a1118-421r · Cited by 32
Self-citationTrung, N. T., Hoan, N. X., Trung, P. Q., Binh, M. T., Tong, H. V., Toàn, N. L., Bang, M. H., & Song, L. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-65213-8 · Cited by 32
Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus
Witt-Kehati, D., Fridkin, A., Alaluf, M. B., Zemel, R. R., & Shlomai, A. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.02.015 · Cited by 30
Liao, B., Zhou, H., Liang, H., & Li, C. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4126 · Cited by 29
Liu, X., He, L., Han, J., Wang, L., Li, M., Jiang, Y., Wang, X., & Yang, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170605 · Cited by 29
Self-citationHan, Q.-J., Hou, Z.-H., Yin, C., Zhang, C., & Zhang, J. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2018.11.006 · Cited by 28
Self-citationMao, X., Tey, S. K., Ko, F. C. F., Kwong, E. M. L., Gao, Y., Ng, I. O., Cheung, S., Guan, X., & Yam, J. W. P. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.12.003 · Cited by 28
Horng, J.-H., Lin, W.-H., Wu, C.-R., Lin, Y., Wu, L., Chen, D., & Chen, P. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00662-x · Cited by 28
Dexamethasone Stimulates Hepatitis B Virus (HBV) Replication Through Autophagy
He, Q., Song, X., Huang, Y., Huang, W., Ye, B., Luo, H., Luo, H., Wu, L., Wang, Z., Chen, W., et al. (2018) · Medical Science Monitor · doi:10.12659/msm.906250 · Cited by 26
Sun, L., Zhang, Y., Zhao, B. L., Deng, M., Liu, J., Li, X., Hou, J., Gui, M., Zhang, S., Li, X., et al. (2014) · Protein & Cell · doi:10.1007/s13238-014-0041-4 · Cited by 25
A direct role for hepatitis B virus X protein in inducing mitochondrial membrane permeabilization
Lee, H., Cho, Y. Y., Lee, G. Y., You, D., Yoo, Y. D., & Kim, Y. J. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12831 · Cited by 24
The antiviral effects of human microRNA miR‐302c‐3p against hepatitis B virus infection
Hamada‐Tsutsumi, S., Naito, Y., Sato, S., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15197 · Cited by 23
Matsuzaki, Y., Chiba, T., Hadama, T., Asaoka, H., Doy, M., Shoda, J., Tanaka, N., & Kinoshita, M. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00249-8 · Cited by 21
Wu, J., Ni, Y., Chen, H., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit638 · Cited by 21
Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status
Song, M., Kwee, S. A., Tiirikainen, M., Hernandez, B. Y., Okimoto, G., Tsai, N. C. S., Wong, L. L., & Yu, H. (2016) · Epigenetics · doi:10.1080/15592294.2016.1151586 · Cited by 21
Tian, J., Liu, W., Zhang, Z., Tang, L., Li, D., Tian, Z., Lin, S., & Li, Y.-J. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.13048 · Cited by 19
Li, M., Zhou, Z., Sun, X., Zhang, X., Zhu, X., Jin, S.-G., Gao, Y., Jiang, Y., & Gao, Y. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.96 · Cited by 18
Self-citationToffanin, S., Cornellà, H., Harrington, A., Llovet, J. M., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.26080 · Cited by 15
Yan, Y., Liu, N., Lu, L., ZANG, C.-M., Shao, B., Li, Y., Wen, Y., Wei, Y., & Cheng, P. (2013) · Oncology Reports · doi:10.3892/or.2013.2531 · Cited by 12
Aicher, S., Kakkanas, A., Cohen, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29078-2 · Cited by 12
MicroRNA-520a suppresses HBV replication in HepG2.2.15 cells by inactivating AKT
Sun, W., Zhang, J., & Chen, J. (2018) · Journal of International Medical Research · doi:10.1177/0300060518792780 · Cited by 11
Self-citation
Cited by
Predictors of early and late hepatocellular carcinoma recurrence
Nevola, R., Ruocco, R., Criscuolo, L., Villani, A., Alfano, M., Beccia, D., Imbriani, S., Claar, E., Cozzolino, D., Sasso, F. C., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i8.1243 · Cited by 274
Metadata
- Authors
- Jiang, Y., Han, Q., Zhao, H., & Zhang, J.
- Venue
- Journal of Hepatocellular Carcinoma
- Publisher
- Informa UK Limited
- Published
- 2021-05
- Volume
- Volume 8
- Pages
- 435-450
- ISSN
- 2253-5969 (ISSN-L)
- OpenAlex
- W3162819955
- Cited by
- 258
- References
- 137
- FWCI
- 25.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.